Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)1033-1035
Number of pages3
JournalLeukemia and Lymphoma
Volume50
Issue number6
DOIs
StatePublished - 2009

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this